Clinical Trials Insight: 700020012

Trial Profile

Clinical Trials Insight: 700020012

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Oct 2008

At a glance

  • Drugs Danoprevir (Primary)
  • Indications Hepatitis C; Viral hepatitis
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors InterMune
  • Most Recent Events

    • 24 Sep 2008 Results will be presented at the 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Oct. 31 to Nov. 4, in San Francisco, California.
    • 01 Nov 2007 Tolerability results reported in an InterMune media release dated 1 Nov 2007.
    • 27 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top